Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma

Liver International

Volumn 25, Issue 2, 2005, Pages 380-388

  Mori, Toshiaki ^a   Nomoto, Shuji ^a   Koshikawa, Katsumi ^a   Fujii, Tsutomu ^a   Sakai, Mitsuru ^a   Nishikawa, Yoko ^a   Inoue, Soichiro ^a   Takeda, Shin ^a   Kaneko, Tetsuya ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Hyper methylation; Loss of heterozygosity; RUNX3

Indexed keywords

BISULFITE; GENOMIC DNA; HEPATITIS C ANTIBODY; RNA; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME 1P; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE INACTIVATION; GENE LOCUS; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 20144388616     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.1059.x     Document Type: Article

References (28)

1. Chen C J, Yu M W, Liaw Y F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: 294-308.
2. Bos J L. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
3. Möröy T, Marchio A, Etiemble J, Trepo C, Tiollasis P, Buendia M A. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 1986; 324: 276-9.
4. Hu Y X, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Okai T, Sawabu N. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin Cancer Res 1997; 3: 1473-7.
5. Wong D J, Barrett M T, Stoger R, Emond M J, Reid B J. P16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res 1997; 57: 2619-22.
6. Tokumaru Y, Nomoto S, Jerònimo C, Henrique R, Harden S, Trink B, Sidransky D. Bialleleic inactivation of the RIZ1 gene in human gastric cancer. Oncogene 2003; 22: 6954-8.
7. Massagu J, Blain S W, Lo R S. TGF β signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
8. Tang B, Böttinger E P, Jakowlew B, Bagnall K M, Mariano J, Anver M R, Letterio J J, Wakefield L M. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 1998; 4: 802-7.
9. Li Q L, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi X Z, Lee K Y, Nomura S, Lee C W, Han S B, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-24.
10. Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 2003; 13: 43-7.
11. Miyazono K, Suzuki H, Imamura T. Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci 2003; 94: 230-4.
12. Herath N I, Kew M C, Whitehall V L, Walsh M D, Jass J R, Khanna K K, Young J, Powell LW, ;Legget B A, Mcdonald G A. P73 is up-regulated in a subset of hepatocellular carcinomas. Hepatology 2000; 31: 601-5.
13. Fang W, Piao Z, Buyse I M, Simon D, Sheu J C, Perucho M, Huang S. Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma. Br J Cancer 2001; 84: 743-7.
14. Blobe G C, Schiemann W P, Lodish H F. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-8.
15. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio A F, Bursch W, Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Sci USA 1992; 89: 5408-12.
16. Gressner A M, Lahme B, Mannherz H-G, Polzar B. TGF-β mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 1997; 26: 1079-92.
17. Furuta K, Misao S, Takahashi K, Tagaya T, Fukuzawa Y, Ishikawa T, Yoshida K, Kakumu S. Gene mutation of transforming growth factor beta 1 type II receptor in hepatocellular carcinoma. Int J Cancer 1999; 81: 851-3.
18. Yakicier M C, Irmak M B, Romano A, Kew M, Ozturk M. Smad2 and Smad4 gene mutation in hepatocellular carcinoma. Oncogene 1999; 81: 4879-83.
19. Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. Am J Pathol 2003; 163: 387-91.
20. Xiao W H, Liu W W. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 376-80.
21. Fang W, Piao Z, Simon D, Sheu J C, Huang S. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Gene Chromosome Cancer 2000; 28: 269-75.
22. Sun M, Eshleman J R, Ferrell L D, Jacobs G, Sudilovsky C, Tuthill R, Hussein M R, Sudilovsky O. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology 2001; 33: 1415-24.
23. Schwab M, Praml C, Amler L C. Genomic instability in 1p and human malignancies. Gene Chromosome Cancer 1996; 16: 211-29.
24. Fang W, Piao Z, Simon D, Sheu J C, Huang S. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Gene Chromosome Cancer 2000; 28: 269-75.
25. Mihara M, Nimura Y, Ichimiya S, Sakiyama S, Kajikawa S, Adachi W, Amano J, Nakagawar A. Absence of mutation of the p73 gene localized at chromosome 1p3.63 in hepatocellular carcinoma. Br J Cancer 1999; 79: 164-7.
26. Yang B, Guo M, Herman J G, Clark D P. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003; 163: 1101-7.
27. Ng I O, Lai E C, Ng M M, Fan S T. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992; 70: 45-9.
28. Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Hirohashi S. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett 2000; 148: 73-80.